• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黎巴嫩实施阿片类激动剂治疗的挑战:基于使用者视角的定性研究。

Challenges in implementing opioid agonist therapy in Lebanon: a qualitative study from a user's perspective.

机构信息

Department of Biomedical Sciences, Lebanese International University, Beirut, Lebanon.

Observatory of Public Policies and Health, Beirut, Lebanon.

出版信息

Subst Abuse Treat Prev Policy. 2018 Apr 19;13(1):14. doi: 10.1186/s13011-018-0151-8.

DOI:10.1186/s13011-018-0151-8
PMID:29673369
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5909215/
Abstract

BACKGROUND

Opioid agonist therapy (OAT) has been implemented for the treatment of individuals with opioid use disorders in Lebanon since 2011, but has not been evaluated yet. The aim of the study is to describe the implementation of the first pilot OAT program in Lebanon from the users' perspective.

METHODS

Data collectors gathered data from male participants during June 2016-July 2016. Eighty-one out of 94 patients agreed to participate in the study. Data regarding access to treatment, satisfaction with the treatment protocol and treatment outcomes, patient-provider relationship, and misuse and diversion was collected through semi-structured qualitative interviews. Data saturation was reached after 81 interviews; once no new themes were reported.

RESULTS

Findings showed inequalities in access to treatment and showed that OAT improved mental and social wellbeing among users who had financial access and complied with the program protocols. Registering in the program protected users from arrest and reduced their economic burden. Among the main encountered challenges were fear of dependence to buprenorphine, restricted geographical access to treatment, misuse and diversion of buprenorphine.

CONCLUSION

Results implicate inequalities in access to OAT as one important gap to be tackled in the management of OAT in Lebanon. Further research should be done in order to understand the challenges in the implementation of the program from the providers' perspectives.

摘要

背景

自 2011 年以来,在黎巴嫩,阿片类药物激动剂疗法(OAT)已被用于治疗阿片类药物使用障碍患者,但尚未对此进行评估。本研究旨在从使用者的角度描述黎巴嫩第一个试点 OAT 项目的实施情况。

方法

数据收集员于 2016 年 6 月至 7 月期间从男性参与者那里收集数据。94 名患者中有 81 名同意参与研究。通过半结构化定性访谈收集了关于治疗途径、对治疗方案和治疗结果的满意度、医患关系以及药物滥用和转用的数据。在 81 次访谈后达到数据饱和,即没有新的主题出现。

结果

研究结果显示,在获得治疗方面存在不平等现象,并且 OAT 改善了有经济能力并遵守项目方案的使用者的心理和社会福利。参加该计划可以保护使用者免受逮捕,并减轻他们的经济负担。主要遇到的挑战包括对丁丙诺啡产生依赖的恐惧、接受治疗的地理限制以及丁丙诺啡的滥用和转用。

结论

研究结果表明,获得 OAT 的机会不平等是黎巴嫩 OAT 管理中需要解决的一个重要差距。为了了解提供者在实施该方案方面遇到的挑战,应该进一步进行研究。

相似文献

1
Challenges in implementing opioid agonist therapy in Lebanon: a qualitative study from a user's perspective.黎巴嫩实施阿片类激动剂治疗的挑战:基于使用者视角的定性研究。
Subst Abuse Treat Prev Policy. 2018 Apr 19;13(1):14. doi: 10.1186/s13011-018-0151-8.
2
Consumer attitudes about opioid addiction treatment: a focus group study in New York City.消费者对阿片类药物成瘾治疗的态度:纽约市的一项焦点小组研究。
J Opioid Manag. 2013 Mar-Apr;9(2):111-9. doi: 10.5055/jom.2013.0152.
3
Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden.作为应对阿片类药物替代治疗障碍的一种方式,长期自我使用美沙酮或丁丙诺啡治疗:瑞典的案例
Harm Reduct J. 2015 Feb 18;12:1. doi: 10.1186/s12954-015-0037-2.
4
Provider and patient perspectives on barriers to buprenorphine adherence and the acceptability of video directly observed therapy to enhance adherence.提供者和患者对丁丙诺啡依从性障碍的看法,以及视频直接观察治疗以提高依从性的可接受性。
Addict Sci Clin Pract. 2019 Mar 13;14(1):11. doi: 10.1186/s13722-019-0139-3.
5
The complex relation between access to opioid agonist therapy and diversion of opioid medications: a case example of large-scale misuse of buprenorphine in the Czech Republic.阿片类激动剂治疗的可及性与阿片类药物滥用之间的复杂关系:以捷克大规模滥用丁丙诺啡为例。
Harm Reduct J. 2018 Dec 4;15(1):60. doi: 10.1186/s12954-018-0268-0.
6
Opiate agonist treatment to improve health of individuals with opioid use disorder in Lebanon.在黎巴嫩,阿片类激动剂治疗改善阿片类药物使用障碍患者的健康状况。
Harm Reduct J. 2017 Dec 8;14(1):78. doi: 10.1186/s12954-017-0204-8.
7
Awareness of, experience with, and attitudes toward buprenorphine among opioid users visiting a New York City syringe exchange program.纽约市一个针头交换项目中阿片类药物使用者对丁丙诺啡的知晓度、使用体验及态度。
J Opioid Manag. 2013 Nov-Dec;9(6):407-13. doi: 10.5055/jom.2013.0183.
8
Methadone and buprenorphine treatment in United States jails and prisons: lessons from early adopters.美国监狱中美沙酮和丁丙诺啡治疗:早期采用者的经验教训。
Addiction. 2021 Dec;116(12):3473-3481. doi: 10.1111/add.15565. Epub 2021 May 25.
9
Long-acting injectable depot buprenorphine from a harm reduction perspective in patients with ongoing substance use and multiple psychiatric comorbidities: a qualitative interview study.从减少伤害的角度来看,对于正在使用物质且伴有多种精神共病的患者,长效注射型丁丙诺啡:一项定性访谈研究。
Harm Reduct J. 2024 Mar 25;21(1):68. doi: 10.1186/s12954-024-00984-1.
10
Integration of a contraception clinic into an opioid treatment setting to improve contraception knowledge, accessibility and uptake: a pilot study.将避孕诊所纳入阿片类药物治疗环境,以提高避孕知识、可及性和接受度:一项试点研究。
Aust N Z J Public Health. 2020 Oct;44(5):360-362. doi: 10.1111/1753-6405.13025. Epub 2020 Aug 31.

引用本文的文献

1
Patient experience of opioid use disorder treatment medications: a systematic review of contemporary qualitative research.阿片类物质使用障碍治疗药物的患者体验:当代定性研究的系统评价
BMJ Open. 2024 Dec 4;14(12):e088617. doi: 10.1136/bmjopen-2024-088617.
2
Interventions to Reduce Opioid Use in Youth At-Risk and in Treatment for Substance Use Disorders: A Scoping Review.减少青少年风险人群和物质使用障碍治疗中阿片类药物使用的干预措施:范围综述。
Can J Psychiatry. 2022 Dec;67(12):881-898. doi: 10.1177/07067437221089810. Epub 2022 May 9.
3
Medication for opioid use disorder in the Arab World: A systematic review.阿拉伯世界阿片类药物使用障碍的药物治疗:系统评价。
Int J Drug Policy. 2022 Apr;102:103617. doi: 10.1016/j.drugpo.2022.103617. Epub 2022 Feb 16.
4
Motivations to initiate injectable hydromorphone and diacetylmorphine treatment: A qualitative study of patient experiences in Vancouver, Canada.启动注射用氢吗啡酮和二乙酰吗啡治疗的动机:对加拿大温哥华患者经历的定性研究。
Int J Drug Policy. 2020 Nov;85:102930. doi: 10.1016/j.drugpo.2020.102930. Epub 2020 Sep 16.
5
The exploration of factors related to treatment retention in Narcotics Anonymous members: a qualitative study.探索美沙酮维持治疗者治疗保持相关因素:一项定性研究。
Subst Abuse Treat Prev Policy. 2019 Apr 11;14(1):14. doi: 10.1186/s13011-019-0205-6.

本文引用的文献

1
Opiate agonist treatment to improve health of individuals with opioid use disorder in Lebanon.在黎巴嫩,阿片类激动剂治疗改善阿片类药物使用障碍患者的健康状况。
Harm Reduct J. 2017 Dec 8;14(1):78. doi: 10.1186/s12954-017-0204-8.
2
Opioid dependency rehabilitation with the opioid maintenance treatment programme - a qualitative study from the clients' perspective.从客户角度看阿片类药物维持治疗方案的阿片类药物依赖康复——一项定性研究
Subst Abuse Treat Prev Policy. 2015 Sep 15;10:35. doi: 10.1186/s13011-015-0031-4.
3
Unobserved "home" induction onto buprenorphine.未观察到的丁丙诺啡“居家”诱导。
J Addict Med. 2014 Sep-Oct;8(5):299-308. doi: 10.1097/ADM.0000000000000059.
4
The current status of opioid maintenance treatment in France: a survey of physicians, patients, and out-of-treatment opioid users.法国阿片类药物维持治疗的现状:对医生、患者和治疗外阿片类药物使用者的调查。
Int J Gen Med. 2014 Sep 9;7:449-57. doi: 10.2147/IJGM.S61014. eCollection 2014.
5
A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world.丁丙诺啡转移与滥用综述:当前的证据基础及全球经验
J Addict Med. 2014 Sep-Oct;8(5):315-26. doi: 10.1097/ADM.0000000000000045.
6
Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users.阿片类药物使用者中丁丙诺啡/纳洛酮的非法使用。
J Addict Med. 2011 Sep;5(3):175-80. doi: 10.1097/ADM.0b013e3182034e31.
7
Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injection and adherence with supervised dosing.在澳大利亚对丁丙诺啡-纳洛酮进行上市后监测:转用、注射和遵医嘱用药。
Drug Alcohol Depend. 2011 Nov 1;118(2-3):265-73. doi: 10.1016/j.drugalcdep.2011.04.002. Epub 2011 May 12.
8
Opiate users' perceived barriers against attending methadone maintenance therapy: a qualitative study in China.阿片类使用者对参加美沙酮维持治疗的认知障碍:来自中国的定性研究。
Subst Use Misuse. 2011;46(9):1190-8. doi: 10.3109/10826084.2011.561905. Epub 2011 Mar 21.
9
The role of patient satisfaction in methadone treatment.患者满意度在美沙酮治疗中的作用。
Am J Drug Alcohol Abuse. 2010 May;36(3):150-4. doi: 10.3109/00952991003736371.
10
The profile of injection drug users in Chennai, India: identification of risk behaviours and implications for interventions.印度钦奈注射吸毒者人群特征:风险行为的识别及其对干预措施的意义。
Subst Use Misuse. 2010 Feb;45(3):354-67. doi: 10.3109/10826080903452447.